Evgen Pharma plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Edward James Norman Wardle, was filed 16 Oct 2025.
Evgen Pharma plc: what insiders have been doing
Evgen Pharma plc, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to RNS (LSE). Nothing new has been filed by managers of Evgen Pharma plc in twelve months, the latest record being from 16 October 2025.
The full history, which starts in 2022, counts 8 purchases against no sales.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and EssilorLuxottica. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Who traded when
BuySaleSince the insiders bought
- -14.3%Entry £0.00 · Close 19 Oct 2026 £0.00
- -12.8%Entry £0.00 · Close at T+365 £0.00
- -71.9%Entry £0.01 · Close at T+365 £0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended March 2025 · cache
- 7,342,296 shares@ £0.0018100.0% of flowOutside a trading venueRNS:5864752Canonical exit: 12 Jan 2026 (T+90)
- 0Outside a trading venueISIN GB00BSVYN304RNS:5665721
- 1,500,000 shares@ £0.0024100.0% of flowXLONISIN GB00BSVYN304RNS:5560566Canonical exit: 2 Jun 2025 (T+90)
- 1,000,000 shares@ £0.01100.0% of flowLondon Stock Exchange, AIM MarketRNS:5132376-4Canonical exit: 4 Jul 2024 (T+90)
- 600,000 shares@ £0.01100.0% of flowLondon Stock Exchange, AIM MarketRNS:5132376-2Canonical exit: 4 Jul 2024 (T+90)
- 1,000,000 shares@ £0.01100.0% of flowLondon Stock Exchange, AIM MarketRNS:5132376-3Canonical exit: 4 Jul 2024 (T+90)
- 0London Stock Exchange, AIM MarketRNS:5132376-0Canonical exit: 4 Jul 2024 (T+90)
- 1,000,000 shares@ £0.01100.0% of flowLondon Stock Exchange, AIM MarketRNS:5132376-1Canonical exit: 4 Jul 2024 (T+90)
- 2,000,000 shares@ £0.01100.0% of flowLondon Stock Exchange, AIM MarketRNS:5132376-5Canonical exit: 4 Jul 2024 (T+90)
- 4,410,727 sharesLondon Stock Exchange, AIMISIN GB00BSVYN304FCA-NSM:4612827-0
- 1,460,855 sharesLondon Stock Exchange, AIMISIN GB00BSVYN304FCA-NSM:4612827-1
11 of 11 declarations
About Evgen Pharma plc
Evgen Pharma plc is a UK-based biopharmaceutical company focused on developing treatments for cancer and neurodegenerative diseases. The company specializes in using gene therapy technology to enhance patient outcomes.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
